Digoxin and Reduction of Heart Failure Hospitalization in Chronic Systolic and Diastolic Heart Failure

In the Digitalis Investigation Group trial, digoxin-associated reduction in the combined end point of heart failure (HF) hospitalization or HF mortality was significant in systolic but not in diastolic HF. To assess whether this apparent disparity can be explained by differences in baseline characte...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Meyer, Philippe, White, Michel, Mujib, Marjan, Nozza, Anna, Love, Thomas E., Aban, Inmaculada, Young, James B., Wehrmacher, William H., Ahmed, Ali
Médium: Artigo
Jazyk:Inglês
Vydáno: 2008
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2633091/
https://ncbi.nlm.nih.gov/pubmed/19064024
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjcard.2008.05.068
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky